1-4 of 4
Anastasia Bykova, MD
Close
Sort by
Journal Articles

Long-Term Results and Characteristics of Pleural Effusion in Late Chronic Phase Chronic Myeloid Leukemia Patients at Dasatinib Therapy after Imatinib Failure

Galina Gusarova, MD PhD, Anastasia Bykova, MD, Alexandra Vorontsova, MD PhD, Sergey Kuznetsov, MD, Oleg Shukhov, MD, Ekaterina Chelysheva, MD PhD, Olga Lazareva, MD PhD, Svetlana Goryacheva, MD PhD, Tatyana Ivanova, MD PhD, Anna G. Turkina, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5141.
https://doi.org/10.1182/blood.V126.23.5141.5141
Published: 2015
Journal Articles

Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

Anastasia Bykova, MD, Adhamjon Abdullaev, MD PhD, Galina Gusarova, MD PhD, Ekaterina Chelysheva, MD PhD, Svetlana Treglazova, MD, Svetlana Smirnova, MD, Anna G. Turkina, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5538.
https://doi.org/10.1182/blood.V124.21.5538.5538
Published: 2014
Journal Articles

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Anna G. Turkina, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Vasiliy Shuvaev, Galina Gusarova, MD PhD, Anastasia Bykova, MD, Olga V. Lazareva, PhD, Oleg Shukhov, MD, Adham Abdullaev, MD PhD, Irina Martynkevich, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 5518.
https://doi.org/10.1182/blood.V124.21.5518.5518
Published: 2014
Journal Articles

Long-Term Results and Adverse Events Of Second Line Nilotinib Therapy After Imatinib Failure In Patients With Chronic Myeloid Leukemia In Chronic Phase In Clinical Practice

Anastasia Bykova, MD, Galina Gusarova, MD, PhD, Ekaterina Yu. Chelysheva, MD, PhD, Anna G. Turkina, MD, PhD,
Journal: Blood
Blood (2013) 122 (21): 5181.
https://doi.org/10.1182/blood.V122.21.5181.5181
Published: 2013